CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical

MassRoots

JANUARY 10, 2019

House Bill 136, an amendment to legalize medical marijuana, was introduced in the Kentucky Legislature on Wednesday, January 9, 2019. Lawmakers have been listening to constituents suffering from debilitating diseases, like epilepsy and cancer, who say they would like to have the option to explore how medical cannabis may ease their symptoms.

Legalization

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients

The Cannigma

APRIL 19, 2021

In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% THC are legal for use by qualifying medical patients. Patients do not need to register with the state or pay a fee to access the medical cannabis program.

Law

The Cannigma

JUNE 1, 2021

Under the plan, some 3,000 patients in France will be treated with medical cannabis and monitored closely. The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs.

Law

Project CBD

MARCH 21, 2023

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus.

Cannabinoids

NORML

MAY 24, 2019

Legislation that would have significantly expanded patient access to medical cannabis in Rhode Island was held in a senate committee for further study, ultimately killing the bill. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

Legislation

MassRoots

AUGUST 3, 2020

Louisiana’s medical marijuana program may have been established three years ago, but patients were not granted access to medicine until August of 2019 when the first round of the product became available. Home cultivation remains illegal for the more than 4,000 registered medical marijuana patients. House Bill 819.

Programs

The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).

Law

Veriheal

NOVEMBER 18, 2022

Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Texas’ Medical Cannabis Program Sees Growth Despite Limitations.

Edibles

Canna Law Blog

MARCH 12, 2019

On January 3, 2019, the PTAB published its Final Written Decision in the case, Insys Development Co, Inc. 9,066,920 – “Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy” (“the 920 Patent”). Epidiolex was approved to treat two rare forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

Epilepsy

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The main goal of the reform is to ease bureaucratic hurdles for patients and to improve the quality and consistency of medical cannabis. Severe epilepsy in minors.

Patients

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions

Illinois News Joint

JULY 31, 2024

During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program.

Conditions

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. GW Pharmaceuticals said in May, Epidiolex was successful in treating seizures in patients with a rare form of childhood epilepsy called tuberous sclerosis complex during a late-stage trial.

Epilepsy

CannaMD

JULY 14, 2020

Polypharmacy is a growing problem where patients are prescribed multiple different medications simultaneously in order to treat a given medical condition. It’s often mistakenly believed that taking multiple medications results in better management of a patient’s symptoms, but often that’s simply not the case. WHAT IS POLYPHARMACY?

Marijuana

MassRoots

FEBRUARY 17, 2019

In 2018, the first full year of operations for the retail medical marijuana program in Pennsylvania, patients spent more than $130 million on the herbal medication. Patients are realizing the benefits and there has been steady, positive progress that I am pleased to report.”. — Senator Jay Costa (@Senatorcosta) February 15, 2019.

Marijuana

The Cannigma

SEPTEMBER 13, 2021

To some extent, cannabis has already been decriminalized for personal use in Israel since 2019, when a law went into effect that reduced the penalties for small-scale possession to a simple fine instead of criminal charges. A decision is made by the director, and the patient has the ability to appeal a rejection to the appeal committee.

Legalization

Illinois News Joint

JANUARY 9, 2025

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. Those four newly added conditions bring the total to 56.

Conditions

CannaTech

APRIL 1, 2020

In practical terms, we studied how pharmaceuticals interact, how to accurately measure and dispense medications, advise patients on effective protocols and adverse events, what to do and not to do when using specific medications. Over 60,000 patients in Israel receive medical cannabis through pharmacies and distributors.

Supply Chain

The Cannigma

SEPTEMBER 28, 2021

Does Irish law permit for medical patients? In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. A patient can access any medical cannabis product for any medical condition with the written approval of the Minister of Health.

Law

The Cannigma

SEPTEMBER 28, 2021

What Irish law permits for medical patients? In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. A patient can access any medical cannabis product for any medical condition with the written approval of the Minister of Health.

Law

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. oz of 5% or less THC oil for medical patients with qualifying conditions. In-state cultivation and distribution weren’t legalized until 2019. Possible penalties.

Law

Cannabis Law Report

MARCH 29, 2019

Chad West March 27, 2019. Texas could make meaningful progress on marijuana-related bills by the end of the 2019 legislative session. Currently, only epilepsy patients may use the drug produced at three state facilities. If passed, S.B. It would also provide for licensing of dispensaries and testing facilities.

Epilepsy

Veriheal

SEPTEMBER 27, 2021

The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? ApprovedButDenied.

Treatment

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC

MMJ Recs

DECEMBER 13, 2023

While the state has traditionally held a conservative stance on cannabis, there has been a gradual shift in public opinion and legislative action, paving the way for a more inclusive and patient-centric approach to healthcare. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary

Cannabis Law Report

JUNE 5, 2019

30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation. Today (30 May) at 09.30 Sick group 1.

Pharmaceutical

Cannabis Law Report

MARCH 21, 2019

Georgia only allows patients diagnosed with cancer, ALS, seizures, and other serious medical conditions to legally possess CBD. In 2014, Mississippi legalized CBD for epileptic patients. THC for patients who suffer from severe epilepsy and is produced in compliance with the North Carolina Industrial Hemp Commission regulations.

State Laws

Veriheal

SEPTEMBER 22, 2020

The cannabis that was approved for medical use was required to have a low THC content, and patients had to register their use of the substance on the Compassionate Use Registry, arguably a violation of their privacy. The 2016 law also established more Medical Marijuana Treatment Centers, making it easier for patients to access cannabis.

Edibles

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. An estimated 250 patients a month are said to be prescribed cannabis medicines through the NHS compared to over 2,500 in the UK’s private sector. Step In Right Direction.

Data

Veriheal

AUGUST 25, 2021

However, rejected applicants, medical marijuana advocates and patients are voicing their concerns over the controversial decision-making process. . The GMCC’s decision to award six cultivation licenses has sparked debate among advocates and patients alike. 21 Companies File Protests Following Rejection .

Cultivation

MassRoots

JULY 30, 2020

Initiatives 65 and 65A would amend Mississippi’s state constitution to allow patients with certain qualifying conditions to access medical marijuana after having been approved by a licensed physician. Patients would be allowed to possess 2.5 ounces at a time, and would be prohibited from smoking cannabis in public spaces.

Marijuana

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients

The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily.

Epilepsy